A343090 logo

HLB SCIENCE Inc. Stock Price

XKON:A343090 Community·₩37.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A343090 Share Price Performance

₩2,080.00
542.00 (35.24%)
₩2,080.00
542.00 (35.24%)
Price ₩2,080.00

A343090 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks
0 Rewards

HLB SCIENCE Inc. Key Details

₩0

Revenue

₩0

Cost of Revenue

₩0

Gross Profit

₩0

Other Expenses

₩0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A343090

Founded
2016
Employees
n/a
CEO
Yoon Jongsun
WebsiteView website
www.hlbscience.com

HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases. Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases. The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023. The company was founded in 2016 and is based in Seoul, South Korea.

Recent A343090 News & Updates

Recent updates

No updates